Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
OraSure Technologies
About
Downloads
  2. Companies
  3. OraSure Technologies
  4. Products
  5. ORAQUICK ADVANCE - HIV-1/2 Rapid ...

ORAQUICK ADVANCE - HIV-1/2 Rapid Antibody Test Kit

SHARE

ORAQUICK RAPID HIV TESTING, ANYTIME, ANYWHERE, MADE EASY. THE ORAQUICK ADVANCE® RAPID HIV-1/2 ANTIBODY TEST DETECTS ANTIBODIES TO HIV-1 AND HIV-2 IN 20 MINUTES.

Most popular related searches
hiv 1
hiv 2
hiv test
hiv testing
infectious disease test
infectious disease testing
whole blood
hiv positive
western blot
disease testing
ORAQUICK RAPID HIV TESTING, ANYTIME, ANYWHERE, MADE EASY.
THE ORAQUICK ADVANCE® RAPID HIV-1/2 ANTIBODY TEST DETECTS ANTIBODIES TO HIV-1 AND HIV-2 IN 20 MINUTES.
  • Rapid:Provides results in 20 minutes enabling patients to learn their status in a single visit and allows HIV positive patients to be connected to care immediately.
  • Flexible:Approved for oral fluid, plasma, fingerstick or venipuncture whole blood specimens. Ideal for both clinical and non-clinical settings.
  • Accurate:Greater than 99% agreement with confirmatory Western blot.1
  • Simple:CLIA-waived for oral fluid, fingerstick and venipuncture whole blood and offers the ability to test in non-traditional testing environments, such as outreach programs and mobile testing clinics. Walk-away procedure allows providers to batch tests, enabling more people to get tested, reducing indirect costs and improving turnaround time.
  • Reliable:Offers patients accurate HIV testing without the need for blood or needles. Pain-free testing with oral fluid means more people get screened, more HIV positive patients are connected to care and fewer people are exposed.
THE CURRENT CDC GUIDELINES URGE ROUTINE HIV SCREENING2The Facts
  • More than 1.2 million people in the U.S. are infected with HIV and the CDC estimates that one in seven don’t know it.3
  • individuals who are unaware of their infection account for ~40% of transmissions.4
  • Fewer than 40% of people in the U.S. have ever had an HIV test.5
Risk-based testing is NOT reaching the goal of identifying all HIV+ people. The CDC guidelines recommend taking these steps to help stop the spread of HIV
  • Screen all people 13-64 years old in all healthcare settings.
  • Identify all HIV+ people. Connect them to care early.
  • Educate people about risk factors to empower them to stay healthy.